NVS
Price
$131.43
Change
+$0.66 (+0.50%)
Updated
Oct 17 closing price
Capitalization
253.25B
9 days until earnings call
Intraday Buy/Sell Signals
OGN
Price
$9.28
Change
-$0.10 (-1.07%)
Updated
Oct 17 closing price
Capitalization
2.41B
11 days until earnings call
Intraday Buy/Sell Signals
Interact to see
Advertisement

NVS vs OGN

Header iconNVS vs OGN Comparison
Open Charts NVS vs OGNBanner chart's image
Novartis AG
Price$131.43
Change+$0.66 (+0.50%)
Volume$1.33M
Capitalization253.25B
Organon & Co
Price$9.28
Change-$0.10 (-1.07%)
Volume$3.36M
Capitalization2.41B
NVS vs OGN Comparison Chart in %
NVS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
OGN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
NVS vs. OGN commentary
Oct 19, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is NVS is a Hold and OGN is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Oct 19, 2025
Stock price -- (NVS: $131.43 vs. OGN: $9.28)
Brand notoriety: NVS and OGN are both not notable
Both companies represent the Pharmaceuticals: Major industry
Current volume relative to the 65-day Moving Average: NVS: 101% vs. OGN: 91%
Market capitalization -- NVS: $253.25B vs. OGN: $2.41B
NVS [@Pharmaceuticals: Major] is valued at $253.25B. OGN’s [@Pharmaceuticals: Major] market capitalization is $2.41B. The market cap for tickers in the [@Pharmaceuticals: Major] industry ranges from $719.7B to $0. The average market capitalization across the [@Pharmaceuticals: Major] industry is $94.08B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

NVS’s FA Score shows that 3 FA rating(s) are green whileOGN’s FA Score has 2 green FA rating(s).

  • NVS’s FA Score: 3 green, 2 red.
  • OGN’s FA Score: 2 green, 3 red.
According to our system of comparison, NVS is a better buy in the long-term than OGN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

NVS’s TA Score shows that 2 TA indicator(s) are bullish while OGN’s TA Score has 5 bullish TA indicator(s).

  • NVS’s TA Score: 2 bullish, 6 bearish.
  • OGN’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, OGN is a better buy in the short-term than NVS.

Price Growth

NVS (@Pharmaceuticals: Major) experienced а +1.08% price change this week, while OGN (@Pharmaceuticals: Major) price change was -3.33% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Major industry was +0.16%. For the same industry, the average monthly price growth was +1.84%, and the average quarterly price growth was +19.16%.

Reported Earning Dates

NVS is expected to report earnings on Oct 28, 2025.

OGN is expected to report earnings on Oct 30, 2025.

Industries' Descriptions

@Pharmaceuticals: Major (+0.16% weekly)

The Major Pharmaceuticals industry includes companies that are involved in various processes of creating drugs to treat/prevent diseases. These companies engage in research, testing and manufacturing, as well as the distribution of pharmaceuticals into markets. Johnson & Johnson, Merck & Co., Inc., Pfizer Inc. and Novartis are among the largest companies in this category.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
NVS($253B) has a higher market cap than OGN($2.41B). NVS has higher P/E ratio than OGN: NVS (19.16) vs OGN (3.45). NVS YTD gains are higher at: 39.926 vs. OGN (-36.375). NVS has higher annual earnings (EBITDA): 22.7B vs. OGN (1.5B). NVS has more cash in the bank: 7B vs. OGN (599M). OGN has less debt than NVS: OGN (8.9B) vs NVS (32.6B). NVS has higher revenues than OGN: NVS (55.2B) vs OGN (6.28B).
NVSOGNNVS / OGN
Capitalization253B2.41B10,489%
EBITDA22.7B1.5B1,515%
Gain YTD39.926-36.375-110%
P/E Ratio19.163.45555%
Revenue55.2B6.28B879%
Total Cash7B599M1,169%
Total Debt32.6B8.9B366%
FUNDAMENTALS RATINGS
NVS: Fundamental Ratings
NVS
OUTLOOK RATING
1..100
84
VALUATION
overvalued / fair valued / undervalued
1..100
16
Undervalued
PROFIT vs RISK RATING
1..100
13
SMR RATING
1..100
29
PRICE GROWTH RATING
1..100
46
P/E GROWTH RATING
1..100
46
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
NVSOGN
RSI
ODDS (%)
Bearish Trend 3 days ago
47%
Bullish Trend 3 days ago
55%
Stochastic
ODDS (%)
Bearish Trend 3 days ago
48%
Bullish Trend 3 days ago
55%
Momentum
ODDS (%)
Bearish Trend 3 days ago
45%
Bearish Trend 3 days ago
64%
MACD
ODDS (%)
Bearish Trend 3 days ago
44%
Bearish Trend 3 days ago
59%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
50%
Bearish Trend 3 days ago
70%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
46%
Bearish Trend 3 days ago
69%
Advances
ODDS (%)
Bullish Trend 3 days ago
50%
Bullish Trend 19 days ago
68%
Declines
ODDS (%)
Bearish Trend 7 days ago
44%
Bearish Trend 3 days ago
73%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
41%
Bullish Trend 3 days ago
76%
Aroon
ODDS (%)
Bullish Trend 5 days ago
46%
Bullish Trend 3 days ago
55%
View a ticker or compare two or three
Interact to see
Advertisement
NVS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
OGN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
SHXCX15.260.09
+0.59%
American Beacon Shapiro Equity Opps C
JNGSX12.410.07
+0.57%
Janus Henderson Global Real Estate D
PNAIX84.290.38
+0.45%
T. Rowe Price All-Cap Opportunities-I
IVNCX23.380.10
+0.43%
Macquarie Global Growth Fund Class C
RIVKX20.41-0.05
-0.24%
American Funds International Vntg R-4

NVS and

Correlation & Price change

A.I.dvisor indicates that over the last year, NVS has been closely correlated with GSK. These tickers have moved in lockstep 69% of the time. This A.I.-generated data suggests there is a high statistical probability that if NVS jumps, then GSK could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NVS
1D Price
Change %
NVS100%
+0.50%
GSK - NVS
69%
Closely correlated
+0.32%
AZN - NVS
62%
Loosely correlated
+1.03%
PFE - NVS
59%
Loosely correlated
+1.16%
JNJ - NVS
54%
Loosely correlated
+0.57%
SNY - NVS
50%
Loosely correlated
+1.20%
More

OGN and

Correlation & Price change

A.I.dvisor indicates that over the last year, OGN has been loosely correlated with GSK. These tickers have moved in lockstep 40% of the time. This A.I.-generated data suggests there is some statistical probability that if OGN jumps, then GSK could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To OGN
1D Price
Change %
OGN100%
-1.07%
GSK - OGN
40%
Loosely correlated
+0.32%
BIIB - OGN
40%
Loosely correlated
+0.52%
LLY - OGN
36%
Loosely correlated
-2.02%
SNY - OGN
36%
Loosely correlated
+1.20%
JNJ - OGN
36%
Loosely correlated
+0.57%
More